Exceptional Response to Pembrolizumab in a Patient With Castration-Resistant Prostate Cancer With Pancytopenia From Myelophthisis. Article uri icon

Overview

publication date

  • April 9, 2019

Research

keywords

  • Anemia, Myelophthisic
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • Bone Neoplasms
  • Pancytopenia
  • Prostatic Neoplasms, Castration-Resistant

Identity

Scopus Document Identifier

  • 85067909516

Digital Object Identifier (DOI)

  • 10.1200/JOP.19.00012

PubMed ID

  • 30964731

Additional Document Info

volume

  • 15

issue

  • 6